Wolfe Research analyst Doug Schenkel downgraded 10X Genomics (NASDAQ: TXG) from Outperform to Peerperform.The analyst comments: "We are forecasting ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE